Fevertree Drinks PLC (OTCMKTS:FQVTF – Get Rating) has received an average rating of "Hold" from the fifteen analysts that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $1,319.29.
FQVTF has been the subject of several research reports. Deutsche Bank Aktiengesellschaft lifted their target price on Fevertree Drinks from GBX 900 ($10.86) to GBX 935 ($11.28) in a research report on Monday, September 12th. Royal Bank of Canada boosted their price objective on Fevertree Drinks from GBX 700 ($8.45) to GBX 800 ($9.65) in a research report on Wednesday, September 14th. Berenberg Bank downgraded Fevertree Drinks from a "buy" rating to a "hold" rating in a research report on Friday, September 16th. Finally, JPMorgan Chase & Co. boosted their price objective on Fevertree Drinks from GBX 1,100 ($13.28) to GBX 1,200 ($14.48) in a research report on Thursday, December 1st.
Get
Fevertree Drinks alerts:
Fevertree Drinks Price Performance
OTCMKTS FQVTF opened at $12.81 on Friday. The stock has a 50-day moving average of $12.64 and a two-hundred day moving average of $12.53. Fevertree Drinks has a 1-year low of $8.81 and a 1-year high of $37.36.
About Fevertree Drinks
(Get Rating)
Fevertree Drinks Plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company's products include Indian tonic water, Mediterranean tonic water, elderflower tonic water, Clementine tonic water, ginger beer, ginger ale, and cola distillers.
Featured Articles
- Get a free copy of the StockNews.com research report on Fevertree Drinks (FQVTF)
- Is Kintara Therapeutics A Hidden Gem?
- Should You Warm up to Generac Stock for the Winter?
- 3 High-Yield Dividend Stocks to Hold for the Long Haul
- Cal-Maine Posts Record Quarter, Remain CALM Income Investors
- Tesla Stock: What the Bulls and the Bears Are Getting Wrong
Receive News & Ratings for Fevertree Drinks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fevertree Drinks and related companies with MarketBeat.com's FREE daily email newsletter.
据MarketBeat Ratings报道，Fevertree Drinks PLC(OTCMKTS：FQVTF-GET Rating)从追踪该股的15位分析师那里获得了“持有”的平均评级。一位分析师对该股的评级为卖出建议，八位分析师发布了持有建议，一位分析师对该公司提出了买入建议。在过去一年追踪该股的券商中，1年期目标价平均为1,319.29美元。
FQVTF已经成为几份研究报告的主题。德意志银行Aktiengesellschaft在9月12日星期一的一份研究报告中将Fevertree饮料的目标价从900英镑(10.86美元)上调至935英镑(11.28美元)。9月14日，周三，加拿大皇家银行在一份研究报告中将Fevertree饮料的目标价格从700英镑(8.45美元)上调至800英镑(9.65美元)。贝伦贝格银行在9月16日星期五的一份研究报告中将Fevertree饮料的评级从“买入”下调至“持有”。最后，摩根大通在12月1日周四的一份研究报告中将Fevertree饮料的目标价格从1,100英镑(13.28美元)上调至1,200英镑(14.48美元)。
到达
Fevertree饮料警报：
Fevertree饮料价格表现
OTCMKTS FQVTF上周五开盘报12.81美元。该股的50日移动均线切入位为12.64美元，200日移动均线切入位为12.53美元。费弗特里饮料的一年低点为8.81美元，一年高位为37.36美元。
关于Fevertree饮料
(获取评级)
Fevertree Drinks Plc与其子公司一起，在英国、美国、欧洲和国际上开发和供应优质混合型饮料。该公司的产品包括印度奎宁水、地中海奎宁水、接骨木花奎宁水、克莱门汀奎宁水、姜汁啤酒、姜汁汽水和可乐蒸馏。
专题文章
- 免费获取StockNews.com关于Fevertree饮料的研究报告(FQVTF)
- 金塔拉治疗公司是一颗隐藏的宝石吗？
- 你应该热身到Generac股票过冬吗？
- 长期持有的3只高收益股利股票
- 加州缅因州公布创纪录的季度业绩，保持冷静的收入投资者
- 特斯拉股票：公牛和熊队哪里出了问题
每天收到Fevertree饮料的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯，接收关于Fevertree饮料和相关公司的最新新闻和分析师评级的每日摘要。
